Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself

  • 📰 Forbes
  • ⏱ Reading Time:
  • 93 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 41%
  • Publisher: 53%

United States Headlines News

United States Latest News,United States Headlines

These young biotech entrepreneurs are looking to make billions by editing life itself: by mtindera07

with another Crispr pioneer, 37-year-old Feng Zhang of the Broad Institute of MIT and Harvard.

Crispr is an acronym for “clustered regularly interspaced short palindromic repeats.” It refers to the way bacteria store, in their genomes, snippets of viral DNA, like mug shots. Those markers are used to identify invaders that return, much as a human immune system uses telltale elements of a polio virus remembered from a vaccine.

Haurwitz grew up in Austin, Texas, and earned a bachelor’s degree in biology at Harvard. She didn’t have a clear plan when she went on to UC Berkeley, but she thought she might later become a patent attorney. Haurwitz took a few business classes before getting her Ph.D., then pitched venture capitalists on funding a technology they didn’t really understand. Caribou was securing an exclusive license to some Crispr patents held by the University of California system and the University of Vienna. Still, “pretty much every VC we ­talked to kind of said, ‘Meh,’ ” Haurwitz remembers. This was 2012, and they thought she was overestimating Crispr’s potential.

Caribou licensed to Integrated DNA Technologies the right to sell biology researchers what they’d need for gene-editing experiments. Genus, an animal genetics firm, paid Caribou an undisclosed amount for the exclusive right to use its proprietary Crispr technology to engineer the genes of pigs and other livestock. Similarly, the Jackson Laboratory is paying Caribou to use Crispr to engineer new populations of research mice that model human diseases.

Beyond the competition, there is an intellectual property conflict. Overlapping patent claims from the University of California and the Broad Institute emerged for the foundational technology, which involves an enzyme called Cas9, used to cut DNA. A lawsuit between the institutions was decided in favor of the Broad, but the U.S. Patent Office has granted patents to both.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

mtindera07 What is this? A Denim Jacket Cult? Nahh thanks.

mtindera07 Too bad they’re not trying to improve the human condition instead. They epitomize what’s gone wrong with the US by placing the accumulation of wealth before the advancement of science for the good of humanity.

mtindera07 As with drinking, edit responsibly!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life ItselfEntrepreneurs are taking genetic-editing technology from the lab to the clinic with grand ambitions. But who owns the patents? mtindera07 This will end poorly. mtindera07 Nice mtindera07 Well I could certainly use a revision. Have at me. 🤨
Source: Forbes - 🏆 394. / 53 Read more »

Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life ItselfEntrepreneurs are taking genetic-editing technology from the lab to the clinic with grand ambitions. But who owns the patents? by mtindera07
Source: Forbes - 🏆 394. / 53 Read more »

Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life ItselfEntrepreneurs are taking genetic-editing technology from the lab to the clinic with grand ambitions. But who owns the patents?
Source: Forbes - 🏆 394. / 53 Read more »

Roche pushes back Spark takeover again as regulatory review drags onSwiss drugmaker Roche is pushing back its $4.3 billion takeover offer for gene t...
Source: Reuters - 🏆 2. / 97 Read more »

Breakingviews - Three reasons a wonder drug can cost $5 mln(Reuters Breakingviews) - Novartis's gene therapy for spinal muscular atrop... The actual reasons are greed, Pharma's greedy executives and more greed. SenSanders NYforSanders People4Bernie ArabsForBernie thinkprogress justicedems WHO Not sure how I feel about this or what the best price is, but if it's a one time cure for a fatal and expensive disease, I can see how a high price would be justified. [$5 mln = $5 million] There's usually only one reason: greed.
Source: Reuters - 🏆 2. / 97 Read more »

Commentary: Novartis CEO says gene therapies promise to upend US health system, pricing structureThe current global health system treats chronic diseases with a pay-as-you-go model, spreading costs over months and years. It's unprepared to pay for a surge of new, single-treatment therapies with the potential to provide a lifetime of benefit. Gee ! Surprise! Surprise! Just another infomercial. Going short or long - “FREE MARKET” slugs !
Source: CNBC - 🏆 12. / 72 Read more »

Lawbreakers to lawmakers? The 'criminal candidates' standing in India's electionThe Bharatiya Janata Party (BJP) has one unwanted lead in this month's gene... MunsifV zebatweets This is how PMModi has made in india proud -Record no of criminals as candidates bjpgoondas ModiPressConference Modilie MunsifV zebatweets Fake News
Source: Reuters - 🏆 2. / 97 Read more »

Gene Simmons delivers briefing at Pentagon podium that has not seen a spokesperson in almost a yearKISS frontman Gene Simmons conducted only the second on-camera press briefing at the Department of Defense in the past year. The last person to stand at the podium was movie star Gerard Butler, who was there in October to promote a new movie. Gene Simmons looks like a fire damaged waxwork of Gene Simmons If he wore full makeup I don't think he'd have been invited Veep ended just in time. The Trump administration is beyond parody.
Source: CNN - 🏆 4. / 95 Read more »

Three reasons a wonder drug can cost $5 mlnNovartis’s gene therapy for a deadly disease looks likely to set a record. There are justifiable factors, like the value it delivers and drugmakers’ high development costs. Then there are less palatable ones, including an inefficient U.S. market with a tolerance for high prices. Reuters rob_cyran Profit and greed must come before everything else. rob_cyran But people STILL won't understand.
Source: Breakingviews - 🏆 470. / 51 Read more »

The Unfulfilled Promise of DNA TestingGenetic testing provides families and doctors a wealth of new information. But the medical world is making rapid advances in understanding what the data means, and that’s whipsawing diagnoses and treatment. Mans capacity to act like an all knowing deity never ceases to amaze me... we have such a tiny understanding of the grandeur of the human genome and yet as act as if we understand... it is equal to exploring the Grand Canyon at night with a flashlight.. Just a small voice in the wind. Throughout modern history, humans have thought they knew all the answers. Hell, we haven’t a clue of how many ?s there R. DNA is 1. The difference between”science”& most”religions”? The answers in science never = the ?s Aww what a beautiful sweet little girl. I hope she gets the help she needs.
Source: WSJ - 🏆 98. / 63 Read more »